TISSUE-SPECIFIC FC-GAMMA AND COMPLEMENT RECEPTOR EXPRESSION BY ALVEOLAR MACROPHAGES DETERMINES RELATIVE IMPORTANCE OF IGG AND COMPLEMENT IN PROMOTING PHAGOCYTOSIS OF PSEUDOMONAS-AERUGINOSA

被引:32
作者
BERGER, M
NORVELL, TM
TOSI, MF
EMANCIPATOR, SN
KONSTAN, MW
SCHREIBER, JR
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PEDIAT,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PATHOL,CLEVELAND,OH 44106
关键词
D O I
10.1203/00006450-199401000-00015
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Because the expression of IgG Fc receptors and complement receptors on macrophages may vary in a tissue-specific manner, we used monoclonal antibodies and flow cytometry to define the expression and function of opsonin receptors on fresh normal and cystic fibrosis (CF) bronchoalveolar lavage (BAL) macrophages. Using flow cytometry to separately analyze individual types of cells, we then determined the relative contributions of IgG and complement to phagocytosis of Pseudomonas aeruginosa by fresh BAL cells, avoiding alterations in receptor expression due to in vitro purification or culturing techniques. Neither normal nor CF BAL macrophages express appreciable amounts of the complement receptors CR1, CR2, or CR3. These results were confirmed by immunohistochemical staining of fixed lung sections. BAL macrophages express a high-affinity IgG receptor, Fc gammaRI, that is not found on neutrophils (PMN). In contrast, chemoattractant-stimulated blood PMN express large amounts of CR1 and CR3 but do not express Fc gammaRI. These results correlate with phagocytosis assays, which show that phagocytosis by macrophages is enhanced by relatively low concentrations of IgG but that the addition of complement does not further increase their phagocytosis. In contrast, low concentrations of IgG alone do not promote phagocytosis by PMN, whereas addition of complement markedly enhances phagocytosis by PMN. These results may explain the previously reported sensitivity of macrophages rather than PMN to the ''blocking'' effects of anti-Pseudomonas antibodies from CF patients, and emphasize the pathologic significance of interference with IgG and complement mediated opsonization in the lung in CF.
引用
收藏
页码:68 / 77
页数:10
相关论文
共 28 条
[1]  
BERGER M, 1991, CLIN REV ALLERG, V9, P119
[2]   HUMAN-NEUTROPHILS INCREASE EXPRESSION OF C3BI AS WELL AS C3B RECEPTORS UPON ACTIVATION [J].
BERGER, M ;
OSHEA, J ;
CROSS, AS ;
FOLKS, TM ;
CHUSED, TM ;
BROWN, EJ ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (05) :1566-1571
[3]   COMPLEMENT RECEPTOR EXPRESSION ON NEUTROPHILS AT AN INFLAMMATORY SITE, THE PSEUDOMONAS-INFECTED LUNG IN CYSTIC-FIBROSIS [J].
BERGER, M ;
SORENSEN, RU ;
TOSI, MF ;
DEARBORN, DG ;
DORING, G .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1302-1313
[4]   INCREASED EXPRESSION OF COMPLEMENT DECAY-ACCELERATING FACTOR DURING ACTIVATION OF HUMAN-NEUTROPHILS [J].
BERGER, M ;
MEDOF, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (01) :214-220
[5]   OPSONIC DEFECT IN PATIENTS WITH CYSTIC FIBROSIS OF PANCREAS [J].
BIGGAR, WD ;
HOLMES, B ;
GOOD, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1971, 68 (08) :1716-&
[6]   NONOPSONIC ANTIBODIES IN CYSTIC-FIBROSIS - PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE-SPECIFIC IMMUNOGLOBULIN-G ANTIBODIES FROM INFECTED PATIENT SERA INHIBIT NEUTROPHIL OXIDATIVE RESPONSES [J].
EICHLER, I ;
JORIS, L ;
HSU, YP ;
VANWYE, J ;
BRAM, R ;
MOSS, R .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1794-1804
[7]   CYSTIC-FIBROSIS PSEUDOMONAS OPSONINS - INHIBITORY NATURE IN AN INVITRO PHAGOCYTIC ASSAY [J].
FICK, RB ;
NAEGEL, GP ;
MATTHAY, RA ;
REYNOLDS, HY .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :899-914
[8]   PROTEINS OF THE CYSTIC-FIBROSIS RESPIRATORY-TRACT - FRAGMENTED IMMUNOGLOBULIN-G OPSONIC ANTIBODY CAUSING DEFECTIVE OPSONOPHAGOCYTOSIS [J].
FICK, RB ;
NAEGEL, GP ;
SQUIER, SU ;
WOOD, RE ;
GEE, JBL ;
REYNOLDS, HY .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (01) :236-248
[9]   MODULATION OF SURFACE CD11/CD18 GLYCOPROTEINS (MO1, LFA-1, P150,95) BY HUMAN MONONUCLEAR PHAGOCYTES [J].
FREYER, DR ;
MORGANROTH, ML ;
ROGERS, CE ;
ARNAOUT, MA ;
TODD, RF .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (02) :272-283
[10]  
GUYRE PM, 1989, J IMMUNOL, V143, P1650